IMMUNOGENICITY OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23)-NAÏVE AND PREVIOUSLY IMMUNIZED ADULT PATIENTS WITH SEVERE CHRONIC KIDNEY DISEASE (ID 188)

Session Name
Vaccines - Pneumococcal Vaccines Development
Presenter
  • Marina Ulanova, Canada
Authors
  • Marina Ulanova, Canada
  • Brenda Huska, Canada
  • Angele Desbiens, Canada
  • William McCready, Canada